IL33 and Granuloma: The trends observed in the present study are in the same direction, with the absence of IL-33 not affecting the development of pathology (Fig. 3a) nor the number and size of granulomas in the intestines of IL-33−/− mice at time points beyond the 6 wpi (Fig. 3c, d).